Two pharmaceutical companies, Pfizer and Biontech, are testing a combined vaccine against Covid-19 and influenza. For the first time in the United States, 180 participants aged 18 to 64 were given a single dose of mRNA vaccine. At the first stage, it is examined whether the substance triggers a reaction of the immune system.
The manufacturers say the new combination vaccine is aimed at protecting people against two serious respiratory diseases at the same time. The vaccine combines a flu vaccine candidate from Pfizer and an adapted and currently approved Covid-19 vaccine from two companies’ Omicron variants BA.4 and BA.5. They share development costs.
Combination of two indications
“By combining both indications in a single vaccine approach, we want to offer people an effective way to immunize themselves against two serious respiratory diseases caused by ever-evolving viruses for which there is a constant need for adapted vaccines,” says Uğur Şahin, co-founder of Biontech. (57). (pbe)
Source :Blick
I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.
